Drug General Information
Drug ID
D0IX1V
Former ID
DNC013654
Drug Name
1-(10-Bromoanthracen-9-yl)-2-aminopropane
Drug Type
Small molecular drug
Indication Discovery agent Investigative [529336]
Structure
Download
2D MOL

3D MOL

Formula
C17H16BrN
Canonical SMILES
CC(CC1=C2C=CC=CC2=C(C3=CC=CC=C31)Br)N
InChI
1S/C17H16BrN/c1-11(19)10-16-12-6-2-4-8-14(12)17(18)15-9-5-3-7-13(15)16/h2-9,11H,10,19H2,1H3
InChIKey
TUYLBDQSCRSJBH-UHFFFAOYSA-N
PubChem Compound ID
Target and Pathway
Target(s) 5-hydroxytryptamine 2A receptor Target Info Inhibitor [529336]
KEGG Pathway Calcium signaling pathway
Neuroactive ligand-receptor interaction
Gap junction
Serotonergic synapse
Inflammatory mediator regulation of TRP channels
PANTHER Pathway 5HT2 type receptor mediated signaling pathway
Reactome Serotonin receptors
G alpha (q) signalling events
WikiPathways Serotonin Receptor 2 and STAT3 Signaling
Serotonin Receptor 2 and ELK-SRF/GATA4 signaling
SIDS Susceptibility Pathways
Monoamine GPCRs
GPCRs, Class A Rhodopsin-like
Gastrin-CREB signalling pathway via PKC and MAPK
GPCR ligand binding
GPCR downstream signaling
GPCRs, Other
References
Ref 529336Bioorg Med Chem. 2008 Apr 15;16(8):4661-9. Epub 2008 Feb 14.The role of lipophilicity in determining binding affinity and functional activity for 5-HT2A receptor ligands.
Ref 529336Bioorg Med Chem. 2008 Apr 15;16(8):4661-9. Epub 2008 Feb 14.The role of lipophilicity in determining binding affinity and functional activity for 5-HT2A receptor ligands.

If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.